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Abstract: Acanthamoeba keratitis is a serious pathogenic corneal disease, 
with challenging diagnosis. Standard diagnostic methods include corneal 
biopsy (involving cell culture) and in vivo reflection corneal microscopy (in 
which the visualization of the pathogen is challenged by the presence of 
multiple reflectance corneal structures). We present a new imaging method 
based on fluorescence sectioned microscopy for visualization of 
Acanthamoeba. A fluorescent marker (MT-11-BDP), composed by a 
fluorescent group (BODIPY) inserted in miltefosine (a therapeutic agent 
against Acanthamoeba), was developed. A custom-developed fluorescent 
structured illumination sectioned corneal microscope (excitation 
wavelength: 488 nm; axial/lateral resolution: 2.6 μm/0.4-0.6 μm) was used 
to image intact enucleated rabbit eyes, injected with a solution of stained 
Acanthamoeba in the stroma. Fluorescent sectioned microscopic images of 
intact enucleated rabbit eyes revealed stained Acanthamoeba trophozoites 
within the stroma, easily identified by the contrasted fluorescent emission, 
size and shape. Control experiments show that the fluorescent maker is not 
internalized by corneal cells, making the developed marker specific to the 
pathogen. Fluorescent sectioned microscopy shows potential for specific 
diagnosis of Acanthamoeba keratitis. Corneal confocal microscopy, 
provided with a fluorescent channel, could be largely improved in 
specificity and sensitivity in combination with specific fluorescent marking. 
© 2012 Optical Society of America 
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1. Introduction 
Acanthamoeba keratitis is a rare but serious water-borne parasitic infection of the eye caused 
by the ubiquitous protozoa Acanthamoeba, which can result in permanent visual impairment 
or blindness. Diagnosing Acanthamoeba keratitis is a clinical challenge. Initial symptoms 
resemble those of bacterial keratitis [1–3], although the clinical management of 
Acanthamoeba keratitis differs substantially. As a result, a rapid and accurate identification of 
the parasite is crucial to guide the appropriate intervention [4]. 
The standard diagnosis for Acanthamoeba keratitis in suspect patients is made by culture 
and isolation of organisms from a corneal culture or detection of trophozoites and/or cysts on 
histopathology [5]. This requires corneal scrapping or collection of a corneal biopsy, and 
typically takes days to confirm diagnosis. However, a negative culture does not necessarily 
rule out Acanthamoeba infection. Molecular diagnostic assays (based on Polymerase Chain 
Reaction Analysis) have proved to be more rapid [6–10], as well as more sensitive and 
specific than smear and culture, but they still require corneal scraping to obtain the samples 
[11], as well as trained personnel. 
In vivo corneal confocal microscopy was proposed in the 90’s [11–14] for diagnostic non-
invasive imaging of Acanthamoeba keratitis, and today it has become a major diagnostic tool 
of this disease [15–17]. In vivo confocal microscopy is based on the acquisition of reflectance 
images of corneal micro-structures, therefore relying on changes of reflectivity and/or index 
of refraction of the specimens. The identification of the organisms is therefore purely 
morphological. However, the multiple reflecting structures in the corneal epithelium and 
stroma present in the standard confocal microscopy images make this identification 
challenging, and liable to false positives and negatives. While cysts (10-25 μm in diameter) 
appear to be more reflective, trophozoites (15-45 μm in diameter) have low reflectance and, in 
general, are difficult to identify. 
While imaging techniques are most promising for the diagnosis of Acanthamoeba 
keratitis, due to their capability of rapid detection and non-invasiveness, efforts are still 
needed to increase their sensitivity and to relieve the need of image analysis and interpretation 
from the clinician. These techniques should rely on specific signatures of the pathogen, either 
endogenous or exogenous. 
Non-optical imaging techniques (high resolution 1(H) Nuclear Magnetic Resonance 
Spectroscopy) have been suggested for clinical diagnosis of Acanthamoeba keratitis, 
analyzing its biomechanical profile, and have proved able to identify Acanthamoeba isolates 
with high specificity and sensitivity [18]. However, it is unlikely that this technique may ever 
be generalized for in vivo diagnosis in a clinical standard ophthalmology setting. Multiphoton 
fluorescence microscopy has also been suggested as a potential technique for differential 
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diagnosis of corneal keratitis [19]. However, and probably because of the lack of endogenous 
fluorescence specific to the pathogen, preliminary data available in the literature do not show 
specific differentiation from other corneal structures, although a Second Harmonic Generation 
mode demonstrated altered collagen distribution in the infected corneal regions. Again, 
although back-scattered and forward-scattered light multiphoton microscopy of the cornea has 
been demonstrated in vitro, its in vivo application is still pending [20,21]. 
Selective pathogen marking, in combination with confocal microscopy, appears as a 
realistic route for sensitive and specific in vivo imaging diagnosis of Acanthamoeba keratitis. 
The use of fluorescent agents in ocular surface diagnosis is common. In the case of 
Acanthamoeba sp. standard immunofluorescence methods by means of Acanthamoeba-
specific antisera [22] have been used occasionally to visualize throphozoites and cysts in 
vitro. In addition, acridine orange [23] (a DNA/RNA fluorescent marker) and calcofluor white 
[24] (a fluorophore with high affinity for polysaccharides), have been shown to label cysts in 
corneal scrapings and in contact lens solution. Unfortunately, the lack of specificity of these 
fluorescent markers may be a serious drawback for the intended diagnostic applications. On 
the other hand, in vivo direct visualization of the pathogen in infected corneas by fluorescence 
optical methods remains, to our knowledge, to be demonstrated [25]. 
In this study, we present a new suitable fluorescence probe for Acanthamoeba and the 
fluorescence imaging of the marked pathogen in the corneal stroma of a rabbit infection 
model. The probe is made specific to Acanthamoeba keratitis by covalent linking a 
fluorescent dye to miltefosine, a drug with proven therapeutic potential against Acanthamoeba 
[26]. A home-made sectioned microscope with a fluorescence channel based on structural 
illumination microscopy was used for imaging the labeled pathogens. The specificity of the 
probe, the low concentration of fluorescent marker needed for staining, the therapeutic nature 
of the vehicle, the demonstration of the technique in intact eyes in vitro, and the ready 
availability of in vivo corneal confocal microscopes prepared for fluorescence imaging hold 
promise for a new diagnostic approach of Acanthamoeba keratitis. 
2. Material and Methods 
2.1. Fluorescent marker 
The pathogen fluorescencent marker MT-11C-BDP (Fig. 1(b)) was designed by inserting a 
highly fluorescent and photostable group (BODIPY) within the alkyl chain of miltefosine 
(MT, hexadecylphosphocoline) (Fig. 1(a)). Details of the synthesis and chemical 
characterization are described elsewhere [27]. Alkylphosphocholines, such as miltefosine, are 
quickly internalized by Acanthamoeba spp., showing cytoxicity against the pathogen [28]. 
More specifically, miltefosine has been demonstrated to be useful in the treatment of 
Acanthamoeba keratitis in animal models and has been granted an orphan designation for the 
treatment of Acanthamoeba keratitis in humans by the European Commission:  
 
Fig. 1. (a) The alkylphospholipid miltefosine used as carrier of the fluorescent dye. (b) The 
Acanthomoeba fluorescent marker MT-11C-BDP. 
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http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_desigantion/2009/10/WC5
00006373. 
The fluorescent marker MT-11C-BDP preserves essential structural motifs of the parent 
drug, as the phosphocoline head-group and the lipophilic linear alkyl chain. As a result, the 
antiparasite activity of the marker is identical to that of the original drug [18]. The 
spectroscopic properties of the marker are those of the emitting BODIPY group, with a 
fluorescent excitation maximum at 517 nm and the emission peaking at 525 nm. 
2. 2. Acanthamoeba culture and staining 
Acanthamoeba polyphaga trophozoites (strain 5SU, initially isolated from contact lens from a 
keratitis patient, and obtained from the collection stocks of Department of Parasitology-
Pharmacy School, San Pablo-CEU University Madrid, Spain) were grown at 27°C in PYG + 
5% fetal calf serum during 72 hours [29]. Trophozoites were harvested by centrifugation, 
counted, and resuspended to a concentration of 106 cells/ml, following standard protocols. 
Encystation was obtained by culturing trophozoites in the presence of 50 mM MgCl2 at 30°C 
[26]. 
The trophozoites were stained with MT-11C-BDP prior to inoculation in the infection 
model. The organisms were incubated in 10 μM MT-11C-BDP at 27°C for two hours, 
followed by successive incubations with free-fatty acid BSA in isotonic saline in order to 
eliminate non-internalized molecules. The organisms were washed prior to intrastromal 
injection to ensure that no residual extraamoebic labeled drug remained in the solution prior to 
injection. 
2.3. Corneal infection model 
A New Zealand White rabbit was used as a model for Acanthamoeba corneal keratitis, by 
intrastromal injection [30]. The injection was performed into 1/3 of the anterior stroma 
through a scleral tunnel (3-G needle), parallel to the corneal apex under a surgical microscope. 
The injected solution (0.1 ml) had a concentration of 2·105 cells/ml, with trophozoites 
incubated with 10 μM BDPY-PC for 1 h. The procedure was conducted in vivo with the 
animal under anesthesia with intramuscular ketamine (37.5 mg/kg; Ketolar, Parke-Davis S.A., 
Barcelona, Spain) and intramuscular xylazine (5mg/kg; Rompun, Bayer AG, Leverkusen, 
Germany). In addition, topical anesthesia (0.5% tetracainechlorhydrate and 1 mg 
oxybuprocaine; Colircusí Anestésico Doble, Alcon Cusí, S.A. Barcelona, Spain) was instilled 
in the conjunctival fornix. Clinical signs of white corneal stromal infiltrate were present in all 
animals immediately after injection, and lasted until euthanasia, revealing the presence of the 
intrastromal Acanthamoeba solution. 
For control purposes, 10 μL of a solution of 10 μm fluorescent beads (Fluospheres F-8336, 
Invitrogen) containing 200 beads/μL in PBS was injected into the corneal stroma with 
identical protocols described above. 
A total of 8 rabbits were used in the study. Animals were euthanized with an intravenous 
injection of 150 mg/kg ketamine hydrochloride, and the enucleated eyes measured less than 6 
h post-mortem. The use of animals for this study complies with the ARVO guidelines for 
animal research. Additional control experiments were performed on virgin enucleated porcine 
eyes. Eyes were obtained from a local slaughterhouse within 4 h post-mortem. 
2.4. Fluorescence corneal sectioning microscopy system 
Corneal sectioning microscopy was performed on a home-developed microscope, based on 
structured illumination, which was specifically adapted for fluorescence imaging. Structured 
illumination microscopy allows optical sectioning on a wide-field configuration with similar 
or higher resolution than standard confocal microscopy [31]. Background rejection is based on 
the fact that high-spatial frequencies, associated with detail in an image, attenuate faster than 
lower spatial frequencies with defocus. Projection of a high spatial frequency pattern on the 
focal plane of the sample results in spatial modulation of the in-focus information. Away from 
the focal plane this high-spatial frequency pattern is quickly attenuated and thus information is 
(C) 2012 OSA 1 October 2012 / Vol. 3,  No. 10 / BIOMEDICAL OPTICS EXPRESS  2493
#170423 - $15.00 USD Received 11 Jun 2012; rev. 31 Jul 2012; accepted 31 Jul 2012; published 12 Sep 2012
not modulated out of focus. Demodulation of the 2-D recorded signal allows recovery of the 
in-focus information. 
The system lay-out and properties (for reflectance microscopy) are described in detail 
elsewhere [32]. In brief, a diffraction grating (20DG50, Comar Optics, UK) located on a plane 
conjugate to the focal plane was projected through the objective, producing a 2.25 μm sine 
pattern superimposed to sample image. High-diffracted orders were blocked at the back focal 
plane of the objective. Phase-images required for retrieval of the in-focus information were 
obtained shifting the grating with a piezostage (M-663.465 PI, Germany). Images were 
recorded on a scientific-grade CCD camera (Orca-AG, Hamamatsu Photonics, Japan). 
Imaging was performed at 488 nm using either a x50, NA0.50 (Olympus LMPLFLN 50X, 
NA0.50, w.d. 10.6 mm) dry objective or a x40, NA 0.80 water-immersion long working 
distance objective (Olympus LUMPLFLN 40XW, NA 0.80, w.d. 3.3 mm). Typical total 
exposure time per sectioned image was less than 30 ms. Data transfer and saving reduced the 
overall imaging rate to 3.3 Hz at maximal field of view. Fluorescent beads and an ultrathin 
fluorescent layer dried on a coverslip allowed to determine experimentally the Point Spread 
Function, revealing a lateral resolution of 0.4 to 0.6 μm (depending on the NA of the 
objective) and an axial resolution of 2.6 μm FWHM. Typically, a circular area of 60 μm 
diameter in the sample was measured, with an axial range larger than 500 μm, which allowed 
imaging from the epithelium to beyond the endothelium into the anterior chamber both in the 
rabbit cornea and the porcine corneas. 
A fluorescence channel was also implemented. The excitation light was provided by a CW 
488 nm diode pumped solid state laser (85-BCD, CVI Melles-Griot). A dichroic filter 
(D535/40, with a bandwidth of 515-555 nm, Chroma Technology Corporation, Bellows Falls, 
VT, USA) was placed in the detection channel. 
2.5. Experimental protocols 
Enucleated eyes were placed in custom-designed methacrylate eye-holders mounted on a 
micro-positioning stage in front of the microscope (with the optical axis parallel to the optical 
table). For the purposes of this study the immersion objective (x40) was used. An ophthalmic 
solution (Viscotears, Novartis, refractive index = 1.338 at 488 nm at 25 degrees) allowed 
optically coupling the cornea to the objective. No applanating optics was used. Images were 
typically centered around the corneal apex (although other lateral locations were also tested) 
using a micro-positioning stage (LTA-HS, Newport Co, USA). In-depth scanning was 
performed at Nyquist resolution, from which three-dimensional images of the sample may be 
reconstructed. A 3-D stack was typically run at 3 to 9 μm/s . 
Rabbits were sacrificed 1 hour after injection of the pathogens. The eyes were 
immediately enucleated and kept in DMEM/F12 (Invitrogen Corp., Carlsbad, CA, USA) at 4 
degrees. All measurements were carried out within 6 h post-mortem. 
2.6. Control experiments 
Control experiments were performed to evaluate: (1) the fluorescence sectioned imaging 
capabilities of the microscope within the corneal stroma, (2) the bioactivity and selectivity of 
the fluorescent probe for Acanthamoeba spp.; and (3) the specificity of the compound for 
Acanthamoeba spp., and lack of internalization by healthy corneal cells. 
Fluorescence sectioned microscopy images were obtained on rabbit eyes with corneas 
injected with fluorescence beads, using similar protocols than those followed on corneas 
infected with Acanthamoeba spp. 
Also, the bioactivity and selectivity of MT-11C-BDP was established upon inspection of 
both conventional epifluorescence and optically sectioned fluorescent images of MT-11C-
BDP cultured samples of isolated Acanthamoeba acquired using the instrument described 
above. Samples were incubated in a 5 μM solution of MT-11C-BDP for 30 min at room 
temperature and then imaged on a microscope slide. 
The specificity of the labeling of the pathogen by the fluorescent marker MT-11C-BDP 
was established with the help of a control BODIPY dye (PM567), with a similar structure, 
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excitation and emission spectrum and quantum efficiency to those of MT-11C-BPD, but 
lacking the phosphatidylcholine group head and the alkyl chain. In addition, solutions at the 
same concentration (5 μM) of both MT-11C-BDP and PM567 were topically applied to 
uninfected enucleated porcine eyes and left for incubation for times (90 min) much longer 
than expected in clinical use. Eyes were washed with PBS-BSA prior to imaging. Optically 
sectioned images in eyes with intact corneas and after mechanical removal of the epithelium 
(to guarantee the diffusion of the fluorescent compound inside the stroma) were acquired in a 
non-contact configuration. 
3. Results 
3.1. Evaluation of the corneal infection model 
Figure 2 shows an example of the clinical appearance of the intrastromal infiltrate in rabbit, 
prior to enucleation. The clinical appearance was similar in both the experimental and control 
groups, with clear signs of stromal edema. 
 
Fig. 2. Example of clinical appearance of a rabbit eye (in vivo), following intrastromal 
injection. 
3.2. Control experiments 
Images of the fluorescent beads implanted in the corneal stroma of rabbits were successfully 
achieved in healthy eyes. Figure 3(a) shows a sectioned image (60 μm diameter) of the stroma 
containing a fluorescent bead. 
MT-11C-BDP was efficiently internalized by Acanthamoeba trophozoites, whereas for 
cysts a weak fluorescent rim was observed. Figure 3(b) shows fluorescence sectioned 
microscopic images of a sample of isolated stained organisms (both trophozoits and cysts). 
Their morphology and size matches findings from histopathology. 
MT-11C-BDP was not internalized by healthy corneal cells. Figure 3(c) and 3(d) show the 
side (yz plane) and front (xy plane) views of the corneas of uninfected enucleated porcine 
eyes topically treated with PM567 and MT-11C-BDP, respectively. The vertical white line 
across the side view indicates the axial (z) location of the front (xy) sectioned image, while 
the blue arrow on the front image indicates the x location of the lateral view (yz). The left area 
of the side views (lateral panel of each figure) is the empty space between the objective and 
the cornea, while the right area corresponds to areas within the cornea. Note also that pixels 
have been resized so that the scale is the same in all three dimensions. Figure 3(c) shows that 
the fluorescent emission of PM567 treated eyes is easily detected inside the epithelial cells, 
while their nuclei remain dark. On the other hand, the fluorescent emission of MT-11C-BDP 
treated eyes (Fig. 3(d) originates in a layer (side view) of thickness below resolution (<2.6 
μm), consistent with the plasma membrane of the epithelial outmost cells. No traces of 
fluorescent emission inside the epithelial cells could be detected, confirming that MT-11C-
BDP is not internalized by healthy epithelial cells. Images of de-epithelized corneas treated 
with MT-11C-BDP did not reveal staining of other corneal structures (stromal collagen). 
Figure 3(e) shows images of de-epithelized corneas treated with MT-11C-BDP which did not 
reveal staining of other corneal structures. 
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Fig. 3. (a) Fluorescence sectioned image of a fluorescent bead (10 μm) implanted in the corneal 
stroma of a White New Zealand rabbit. (b) Fluorescence sectioned images of isolated MT-C11-
BDP stained Acanthamoeba trophozoits (green arrows) and cysts (red arrows). (c) Fluorescent 
sectioned image of a porcine cornea after topical application of a solution of the BODIPY 
fluorescent group (PM567, inset) lacking the polar head and the lipidic chain of miltefosine. (d) 
Fluorescent sectioned image of a porcine cornea after topical application of the fluorescent 
marker MT-C11-BDP (miltefosine with a BODIPY group, inset). (e) Fluorescent sectioned 
image of a de-epithelized porcine cornea after topical application of the fluorescent marker 
MT-C11-BDP (miltefosine with a BODIPY group, inset). Figure 3(c), Fig. 3(d) and Fig. 3(e) 
show en face images (xy plane, front view) of the cornea at the plane indicated by the dotted 
line on the lateral plane (yz plane, side view). Epithelial cells in the eye treated with PM567 
(Fig. 3(c)) are clearly identified, as fluorescence originates in the cytoplasm while the nuclei 
remain dark, indicative of the free BODIPY group being internalized by the cells. In contrast, 
all fluorescent emission in the eye treated with MT-11C-BDP (Fig. 3(d)) originates from a thin 
layer at the cornea (plasma membrane of epithelial cells), and no other cellular structure is 
recognized, indicative that when the BODIPY group is bound to miltefosine it is not 
internalized by healthy epithelial cells or other corneal structures. De-epithelized corneas did 
not show any detectable fluorescence signal (Fig. 3(e)) upon treatment with MT-11C-BDP in 
the same conditions as intact corneas (Fig. 3(c) and (d)). No applanating optics or contact 
medium was used (x50 dry objective, see text) for imaging the corneas in Fig. 3(a), Fig. 3(c), 
Fig. 3(d) and Fig. 3(e). Isolated trophozoites and cysts in Fig. 3(b) were imaged through a x40, 
NA1.25 oil objective. 
3.3. Fluorescence imaging of amoebas in situ 
Acanthamoebae implanted in the stroma were successfully imaged by fluorescence sectioned 
microscopy. Figure 4 shows a sectioned images (20 μm depth and 50 μm diameter) of the 
stroma in an infected rabbit eye, where three stained Acanthamoeba trophozoites located at 
the same depth inside the cornea are easily identifiable by their contrasted fluorescent 
emission, with unstained nucleus or vacuole, and their morphological features, such as size 
and shape. The left panel shows axial sections, with the dotted line and arrow indicating the 
axial position of the lateral cross-section shown in the right panel. The right panel shows en 
face views of the Acanthamoebae, with the arrow indicating the lateral location of the 
corresponding axial section shown in the left panel. 
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Fig. 4. Fluorescence sectioned image of several MT-C11-BDP- stained Acanthomoeba 
trophozoites, implanted in the stroma of a rabbit eye. Images were obtained in intact enucleated 
eyes. The left panels show axial images (yz plane, side views). The right panels show en face 
images (xy plane, front view) of the cornea at the plane indicated by the dotted line on the axial 
image. The pathogens are easily identified by their morphological features, such as size and 
shape. A comfort ophthalmic solution was used as immersion medium, but no applanating 
optics was used for imaging (x40W objective, see text). 
4. Discussion 
We have presented a fluorescent marker for specific staining of Acanthamoeba (cysts and 
trophozoites), and its potential for in situ visualization using fluorescence sectioned 
microscopy. Although the concept has been evaluated in vitro, imaging has been conducted on 
enucleated intact eyes, under similar conditions of an in vivo testing. 
The method is, to our knowledge, the first attempt for in situ fluorescent-marker based 
visualization of Acanthamoeba in an infected eye. The specificity and sensitivity of the 
technique exceeds largely that of reflectance corneal confocal microscopy, as the 
morphological identification of the pathogen is not confounded by other reflective corneal 
structures. We have demonstrated that other corneal cells or the intrastromal matrix do not 
internalize the fluorescent compound, making it specific to the pathogen. We have not studied 
the potential for other ocular pathogenic micro-organisms [33] to incorporate miltefosine, but 
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the associated ocular infections by other organisms which could potentially marked by 
miltefosine (i.e. Helminths [34], Trypanosomatids or Leishmania [35–37]) are rare, and the 
pathogens could be easily differentiated by their size and their intracellular pattern. 
The mechanism by which other fluorescent markers (such as PM567 in our control 
experiments) are able to enter the cells, while MT-11C-BDP does not, remains to be 
investigated in full. We hypothesize that PM567 is internalized by a diffusion mechanism, 
while MT-11C-BDP requires a specific molecular transporter to do so. 
The fluorescent marker can also be applied to visualization of Acanthamoeba in corneal 
scrapings or contact lens solutions, but the great potential of the technique relies on its 
promise for in vivo application, which would provide an immediate diagnosis of the suspect 
patient. An additional advantage of the compound is the use of miltefosine, a demonstrated 
therapeutic agent against Acanthamoeba, although it is not lethal at the very low doses used 
for diagnosis. Regarding a possible topical corneal application for diagnostics, our 
experiments show that fluorescent staining of the parasite is much more intense than that of 
the surrounding tissues, likely due to the presence of an active intracellular pumping 
mechanism of the drug by these organisms. For in vitro diagnosis (corneal scrapings, clinical 
isolates) the use of a standard quencher of the residual background fluorescence or 
autofluorescence (Trypan Blue, 0.4%) allows elimination of the fluorescence background. 
Although we have used a custom-developed sectioning microscope in this study, the 
technique could be used with only slight modifications of commercial in vivo corneal confocal 
microscopy, upon the incorporation of a fluorescent channel. Interestingly, a commercial 
instrument [38] (i.e. Heidelberg Retina Tomograph with the Rostock Cornea Module, 
Heidelberg Engineering) is equipped with excitation lasers for retinal fluorescein 
angiography. The wavelength of the laser source (or alternative the excitation peak of the 
fluorescent marker) could be modified for proper excitation. The requirement for optical 
sectioning should be emphasized. In conventional wide field fluorescent microscopy, the 
fluorescent emission of the residual drug accumulating on the outside membrane of healthy 
epithelial cells may hinder the emission from the pathogens. Also, the infiltrates can be 
multifocal and, in a clinical setting, the amoebae are not necessarily most numerous in the 
area of the most obvious infiltrate. The use of a scanning sectioning technique, however, has 
become common practice in the evaluation of Acanthomoeba keratitis subjects. Besides the 
topical application of the fluorescent compound and use of the fluorescent mode of the 
instrument, corneal examination for Acanthomoeba keratitis with the proposed method could 
follow similar protocols than those currently performed with the reflectance corneal confocal 
microscope. 
In this study, the pathogens were stained before injection in the corneal stroma. 
Interestingly, the lifetime of the probe was at least 6 h, a timeline much longer than that of a 
typical clinical examination. However, the diffusion of the compound in the stroma of an 
infected eye and the subsequent staining of the pathogens in situ remains to be tested. Clinical 
application of the method could involve de-epithelization of the patient’s cornea to facilitate 
the diffusion of the compound for fluorescent imaging. Alternatively, the use of drug delivery 
formulations capable of transporting the compound through the corneal epithelium barrier can 
be explored [39]. Toxicology tests are also pending. However, the low concentrations of the 
fluorescent compound (more than three orders of magnitude lower than standard fluorescein 
routinely used topically on the cornea) and the lack of chemical reactivity of the emitting 
group anticipate low toxicity potential. On the other hand, miltefosine is an approved 
compound for topical application in the eye for therapeutical treatment of Acanthamoeba 
keratitis, with a concentration ~16 times higher than that used in the current study for 
diagnostic purposes [40]. 
Finally, in vivo application of the technique would require slightly lower corneal incident 
power than that used in the current in vitro study, in order to remain within the standards of 
maximum permitted exposure (0.065 μJ for a SIM microscope or 0.045 μJ for a confocal 
microscope for an imaged area of 0.01 mm2 at the illumination wavelength used in this work 
(American National Standards Institute (ANSI)). Different hardware configurations of the 
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instrument would make the system more light-efficient, such as a different imaging strategy 
(confocal, line scanning, etc.), longer excitation wavelength or more sensitive detectors, 
among others. On the other hand, the study has been performed under very conservative 
compound concentrations, and it is likely that doses may increase after a drug-toxicity study. 
5. Conclusions 
We have shown a fluorescent-based sectioned microscopy imaging technique for visualization 
of Acanthamoeba keratitis, with highly specific labeling for the pathogens (and no other 
internal corneal structures) in a rabbit model. The selective marker is based on a bright, photo-
stable, fluorescent compound (a BODIPY chromophore) inserted into the lipid tail of 
miltefosine, an approved therapeutic drug for Acanthamoeba, which provides it with high 
specificity. Optical sectioning allows acquisition of high contrast images that would otherwise 
be masked by a strong fluorescent background from the membrane of epithelial cells. In vivo 
confocal corneal microscopes, available clinically, could be modified to add the fluorescence 
channel required for fluorescence detection. The technique holds promise for in vivo diagnosis 
of Acanthamoeba keratitis. 
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